Anti-Human CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-420CQ)

Add to basket Submit an inquiry form Compare

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:

Isotype :

Purity :

Endotoxin :

Quantity :

Conjugation :

Fc Engineering :

Modalities :

Other Requirements:

Inquiry

• Tested Data
• Gene Expression
• Datasheet
• MSDS
• COA

SDS-PAGE

Figure 1 Anti-CD3E Recombinant Antibody (TAB-420CQ) in SDS-PAGE

SDS-PAGE analysis of TAB-420CQ in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.

SEC-HPLC

Figure 2 Anti-CD3E Recombinant Antibody (TAB-420CQ) in HPLC

The purity of TAB-420CQ was greater than 95% as determined by SEC-HPLC.

Subcellular Location and Protein Expression

Figure 1 IF staining of human cell line JURKAT
(Immunofluorescent staining of human cell line JURKAT shows localization to plasma membrane & endoplasmic reticulum.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/40957/1970_E5_1_selected.jpg

Normal Tissue

Figure 2 Lymph node
(Non-germinal center cells
Staining:Medium
Intensity: Moderate
Quantity: 75%-25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/72864/157655_A_9_8.jpg

RNA Expression

Figure 3 RNA cell line category: Group enriched (JURKAT, MOLT-4)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000198851-CD3E

 Datasheet

 MSDS

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Specifications

Product Property

Target

Related Resources

Product Notes

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "visilizumab"

Anti-CD3E Recombinant Antibody (Visilizumab)

Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease.

Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-714)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. It is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease.

DrugMonitor™ Anti-Visilizumab Antibody (VS-1224-YC1307)

Visilizumab has been investigated for ulcerative colitis treatment. The DrugMonitor™ Anti-Visilizumab Antibody (VS-1224-YC1307) is an anti-drug antibody (ADA) against Visilizumab. This drug-based antibody is raised in mice immunized with the Visilizumab. The anti-Visilizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Visilizumab in samples.

See other products for "CD3E"

Customer Reviews and Q&As

Popular products with customers

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.